Peter Phillips, Chief Technology Officer
Peter took Anson Medical Limited from concept to commercial reality in 1997 and with Professor Brian Hopkinson, designed the Aorfix™ stent graft. Before the commercialisation of Anson Medical Limited, Peter ensured that the design concepts were protected by patents, providing the basis for the Cardiovascular Devices Division’s current portfolio. Prior to Anson Medical Limited, Peter was New Products Director at Surgicraft, an orthopaedics company. Prior to that he was a consultant to the diagnostics industry for six years, while working for Scientific Generics and Cambridge Consultants. He has an MSc in medical physics and a PhD in vascular imaging from Guy’s Hospital, London.
In August 2006 he was appointed as President of the new US operatiions based in Boston, set up initially to support the Aorfix™ US clinical trial.
Peter returned to the UK in July 2009 and was appointed Chief Technology Officer, with a number of responsibilities including Key Opinion Leader development and Key Account development in the 5 major markets in EU as well as the US.
